Status:
COMPLETED
Chatbot for Depression, Anxiety, and Eating Disorders
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Conditions:
Depression
Anxiety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The research team would like to test how efficacious an artificial intelligence chatbot is in delivering supportive behavioral interventions in populations with anxiety, depression, or eating concerns...
Detailed Description
The research team has developed a deep learning-powered application that can provide support and therapeutic suggestions via natural dialogue. The chatbot is designed to be highly scalable such that i...
Eligibility Criteria
Inclusion
- We will recruit participants online using Facebook, Google Ads, Reddit, MTurk, listservs, and other online platforms.
- These individuals must meet the criteria for anxiety, depression or disordered eating, according to the PHQ-9, GADQ-IV, and SWED 3.0.
Exclusion
- Individuals currently being treated for active suicidality (measured with C-SSRS), Bipolar I/II, and active psychosis will be excluded from the study.
Key Trial Info
Start Date :
March 11 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2024
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT06013137
Start Date
March 11 2024
End Date
August 30 2024
Last Update
June 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth College
Lebanon, New Hampshire, United States, 03766